Lattice Biologics Ltd. (TSX VENTURE: LBL)(“Lattice Biologics” or the “Company”) announces financial results for the first quarter ended December 31, 2015: First Quarter Financial Results (all figures denoted in USD): Lattice Biologics revenue increased to $1,065,654 in the three months ended December 31, 2015. This is compared to $1,037,040 in the three months ended September […]